Morgan Stanley Starts Kodiak Sciences Inc. (KOD) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BofA/Merrill Lynch Starts Kodiak Sciences Inc. (KOD) at Buy
October 29, 2018 6:15 AM EDTBofA/Merrill Lynch analyst Ying Huang initiates coverage on Kodiak Sciences Inc. (NASDAQ: KOD) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Kodiak Sciences Inc.... More
Barclays Starts Kodiak Sciences Inc. (KOD) at Overweight
October 29, 2018 2:28 AM EDTBarclays analyst Gena Wang initiates coverage on Kodiak Sciences Inc. (NASDAQ: KOD) with a Overweight rating and a price target of $20.00.
The analyst is expecting material upside in the equity citing expectations for continued Phase 1 clinical data readouts in FY 2019/2020 which likely further... More
